Amyloid beta1-40 quantification in CSF: comparison between chromatographic and immunochemical methods

A H Simonsen, S F Hansson, U Ruetschi, J McGuire, V N Podust, H A Davies, P Mehta, G Waldemar, H Zetterberg, N Andreasen, A Wallin, K Blennow

Abstract

BACKGROUND/AIMS: Amyloid beta (Abeta) is the principal component of senile plaques, one of the hallmarks of Alzheimer's disease (AD). Evidence is accumulating that soluble aggregates (oligomers) of Abeta are important in the pathogenesis of AD.

METHODS: We compared three different methods for quantification of the 40 amino acid form of Abeta (Abeta40) in CSF, two based on antibodies [ELISA and surface-enhanced laser desorption/ionization-time of flight (SELDI-TOF) with antibody-coated arrays] and one based on direct binding of proteins to a protein array [SELDI-TOF and immobilized metal affinity [copper] (IMAC30)].

RESULTS: CSF Abeta40 concentration was only found to be significantly elevated in AD (127% of control levels; p=0.0095) using SELDI-TOF with IMAC30 arrays.

CONCLUSIONS: These data suggest that the measured Abeta level in CSF may differ depending on whether antibody-based methods are used or not, possibly caused by epitope masking due to Abeta oligomerization or to binding of Abeta to carrier proteins.

OriginalsprogEngelsk
TidsskriftDementia and Geriatric Cognitive Disorders
Vol/bind23
Udgave nummer4
Sider (fra-til)246-50
Antal sider5
ISSN1420-8008
DOI
StatusUdgivet - 2007

Fingeraftryk

Dyk ned i forskningsemnerne om 'Amyloid beta1-40 quantification in CSF: comparison between chromatographic and immunochemical methods'. Sammen danner de et unikt fingeraftryk.

Citationsformater